Ascendis Pharma A/S vs Indonesia Energy Corporation Limited — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while Indonesia Energy Corporation Limited trades at $2.89 (market cap $45.55M). The key difference: Ascendis Pharma A/S is far larger — about 366× Indonesia Energy Corporation Limited's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Indonesia Energy Corporation Limited nearer its low. Which is the better fit depends on your goals.
| ASND | INDO | |
|---|---|---|
Market Cap | $16.67B | $45.55M |
Sector | Health | Energy |
52-Week High | $277.18 | $6.74 |
52-Week Low | $189.74 | $2.49 |
Enterprise Value | $17.04B | $40.92M |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →